| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 |
| filingDate |
2019-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8703563f44c2021d57e293909c285320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71fa59d30bbda24ada9e65f2fba800d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b626f08235fb16a5efd73a6245061b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_355fc2c9e2c977d0999490cd61917c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56520c9283b4f3b983f60144ba0aafdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa020e5dc49768f69c7607a42da203e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1282ff9a745de318896795fa4c4dc5dc |
| publicationDate |
2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020086139-A1 |
| titleOfInvention |
Combination therapy for the treatment of glioblastoma |
| abstract |
This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066465-B2 |
| priorityDate |
2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |